Program Code: SCF-DBI-PECMO-NEURO-0004**
Operational Window: Pre-Cannulation → ECMO Stabilization → Recovery → Decannulation → Long-Term Neurodevelopmental Follow-Up
Primary Objective: Preserve cerebral viability, prevent secondary neurologic injury, maintain neuroimmune and neurovascular integrity, and optimize lifelong developmental outcomes in pediatric ECMO patients.
SECTION 4.1
CLINICAL POSITIONING
Traditional ECMO Neurologic Monitoring
Focuses on:
Neurologic examination
Neuroimaging
EEG
Stroke detection
Seizure detection
SCF-DBI ECMO Neurocritical Care Model
The brain is viewed as:
Master Biological Intelligence Organ
whose preservation governs:
Survival
Recovery
Development
Adaptation
Long-Term Function
Core Principle
Neurologic preservation begins before neurologic injury becomes clinically visible.
SECTION 4.2
ECMO BRAIN PRESERVATION HIERARCHY
Tier I
Cerebral Perfusion Preservation
Maintain:
Cerebral blood flow
Oxygen delivery
Neurovascular coupling
Tier II
Neuroimmune Preservation
Maintain:
Immune balance
Neuroinflammatory control
Self-tolerance
Tier III
Neurovascular Preservation
Maintain:
Blood-brain barrier integrity
Endothelial stability
Glymphatic flow
Tier IV
Developmental Preservation
Maintain:
Synaptogenesis
Neural network maturation
Cognitive reserve
SECTION 4.3
RHENOVA BRAIN PRESERVATION PLATFORM
Strategic Goal
Continuously preserve recoverable neural biology.
Platform Components
Component 1
Cerebral Oxygenation Intelligence
Component 2
Neuroimmune Surveillance
Component 3
Neurovascular Integrity Monitoring
Component 4
Developmental Preservation Monitoring
Component 5
Recovery Intelligence Monitoring
Primary Output
Cerebral Adaptation Intelligence (CAI)
SECTION 4.4
ECMO NEUROCRITICAL CARE OPERATIONS
Continuous Surveillance Domains
Cerebral perfusion
Cerebral oxygenation
Electrical activity
Neuroimmune activity
Neurovascular integrity
Developmental preservation
Core Monitoring Tools
Cerebral NIRS
EEG
Neuroimaging
Neurologic examinations
Biomarker surveillance
SECTION 4.5
CONTINUOUS EEG SURVEILLANCE PROGRAM
Objectives
Detect:
Subclinical seizures
Electrical instability
Cerebral stress
Neurorecovery progression
EEG Risk Categories
Green
Normal activity
Yellow
Adaptive stress
Orange
Threatened neurologic adaptation
Red
Critical neurologic instability
EEG Intelligence Output
Neuroelectrical Integrity Score (NIS)
SECTION 4.6
CEREBRAL NIRS ARCHITECTURE
Strategic Objective
Provide real-time cerebral oxygenation intelligence.
Monitoring Domains
Regional cerebral oxygenation
Cerebral perfusion reserve
Oxygen extraction
Recovery adaptation
Alert Triggers
NIRS decline >10%
Persistent asymmetry
Progressive downward trend
Failure to recover after intervention
RHENOVA Output
Cerebral Oxygen Delivery Index (CODI)
SECTION 4.7
SCF AUTONOMIC NEURO-MULTISYSTEMS (ANMS) ECMO ENGINE
Strategic Position
ANMS functions as:
Master Adaptation Surveillance Engine
Neurocardiac Domain
Monitor:
Perfusion
Cardiac reserve
NCRS
Neurovascular Domain
Monitor:
Cerebral blood flow
EII
BBB integrity
Neuroimmune Domain
Monitor:
Cytokine burden
STRI
Neuroinflammation
Neurometabolic Domain
Monitor:
Lactate
Energy reserve
Cerebral metabolism
Neuroendocrine Domain
Monitor:
Stress adaptation
Recovery reserve
Primary Output
ANMS Composite Intelligence Score
SECTION 4.8
NEUROIMMUNE–NEUROVASCULAR COLLAPSE PREVENTION FRAMEWORK
Clinical Positioning
Neurologic deterioration often begins with:
Endothelial dysfunction
and
Neuroimmune dysregulation
before structural injury appears.
Early Warning Variables
EII decline
STRI decline
CAI decline
NIRS decline
Lactate increase
Risk Categories
Stable
Vulnerable
Threatened
Critical
SECTION 4.9
ACUTE NEUROLOGIC INJURY SURVEILLANCE
Monitor For
Ischemic stroke
Intracranial hemorrhage
Hypoxic-ischemic injury
Seizures
Encephalopathy
Cerebral edema
Immediate Escalation Criteria
Acute neurologic change
Persistent EEG abnormalities
CAI decline >15%
ANMS decline >15%
SECTION 4.10
ECPR NEUROLOGIC RECOVERY PATHWAY
Strategic Objective
Preserve viable neural networks following cardiac arrest.
Phase 1
Cerebral Rescue
Objectives:
Oxygen delivery restoration
Perfusion restoration
Neuroprotection
Phase 2
Cerebral Stabilization
Objectives:
Electrical stability
Endothelial stabilization
Immune stabilization
Phase 3
Recovery Intelligence Activation
Objectives:
Neurorecovery mapping
Developmental planning
Rehabilitation planning
SECTION 4.11
DEVELOPMENTAL PRESERVATION PROGRAM
Applicable Populations
Neonates
Infants
Children
Adolescents
Domains Monitored
Cognitive development
Language development
Executive function
Memory
Psychosocial adaptation
Primary Output
Developmental Recovery Index (DRI)
SECTION 4.12
DAILY ECMO NEUROLOGIC INTELLIGENCE ROUNDS
Required Participants
ECMO Intensivist
Neurologist
Neurocritical Care Specialist
Nursing Lead
Rehabilitation Team
Family Representative
Daily Review
EEG status
NIRS status
CAI
ANMS
Neuroimaging
Recovery trajectory
SECTION 4.13
NEUROLOGIC ESCALATION MATRIX
Level 1
Enhanced Monitoring
Triggers:
Mild NIRS decline
Minor EEG abnormalities
Level 2
Focused Intervention
Triggers:
CAI decline >10%
Neuroimmune activation
Level 3
Multidisciplinary Escalation
Triggers:
Persistent neurologic abnormalities
Progressive ANMS decline
Level 4
Advanced Neurocritical Care Activation
Triggers:
Stroke
Hemorrhage
Severe encephalopathy
Level 5
Neurologic Rescue Pathway
Triggers:
CAI <40
Severe adaptation failure
Imminent neurologic collapse
SECTION 4.14
LONGITUDINAL NEURORECOVERY SURVEILLANCE
Monitoring Timeline
ICU Discharge
↓
30 Days
↓
90 Days
↓
6 Months
↓
12 Months
↓
24 Months
↓
Annual Surveillance
Domains
Cognitive outcomes
Educational outcomes
Functional outcomes
Behavioral outcomes
Quality of life
SECTION 4.15
BRAIN PRESERVATION SUCCESS ENDPOINTS
Clinical
Reduced stroke incidence
Reduced seizures
Reduced encephalopathy
Reduced neurologic disability
Recovery
Improved neurodevelopment
Improved functional outcomes
Improved educational outcomes
Biological Intelligence
ANMS >80
CAI >80
NIS >80
STRI >80
EII >80
DRI >80
Sustained neuroadaptive recovery
PAGE 4 COMPLETION
Next Page (Page 5):